Tags

Type your tag names separated by a space and hit enter

Klebsiella oxytoca and Emerging Nosocomial Infections.
Curr Microbiol. 2021 Apr; 78(4):1115-1123.CM

Abstract

Klebsiella oxytoca is rising as a significant opportunistic pathogen causing nosocomial infections in neonates as well as adults. This pathogen's prevalence varies from 2 to 24%, but outbreaks of infections due to multidrug-resistant strains can be fatal in immunocompromised individuals with comorbidities. Klebsiella oxytoca is responsible for a wide range of ailments from colitis to infective endocarditis, other than the common urinary and respiratory tract infections. The microbe's pathogenicity has been attributed to cytotoxins' production- Tilivalline and Tilimycin, in some intestinal disorders. Klebsiella oxytoca is reported to be resistant to a wide range of antibiotics. Here, we have tried to showcase a brief overview of the emergence of Klebsiella oxytoca in healthcare facilities and the nature of resistance in this species of Klebsiella.

Authors+Show Affiliations

Department of Life Sciences, Dibrugarh Univerity, Dibrugarh, Assam, 786004, India.Department of Life Sciences, Dibrugarh Univerity, Dibrugarh, Assam, 786004, India.Department of Life Sciences, Dibrugarh Univerity, Dibrugarh, Assam, 786004, India.Department of Life Sciences, Dibrugarh Univerity, Dibrugarh, Assam, 786004, India.Department of Life Sciences, Dibrugarh Univerity, Dibrugarh, Assam, 786004, India. chetiapankaj@dibru.ac.in.

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

33656584

Citation

Neog, Nakul, et al. "Klebsiella Oxytoca and Emerging Nosocomial Infections." Current Microbiology, vol. 78, no. 4, 2021, pp. 1115-1123.
Neog N, Phukan U, Puzari M, et al. Klebsiella oxytoca and Emerging Nosocomial Infections. Curr Microbiol. 2021;78(4):1115-1123.
Neog, N., Phukan, U., Puzari, M., Sharma, M., & Chetia, P. (2021). Klebsiella oxytoca and Emerging Nosocomial Infections. Current Microbiology, 78(4), 1115-1123. https://doi.org/10.1007/s00284-021-02402-2
Neog N, et al. Klebsiella Oxytoca and Emerging Nosocomial Infections. Curr Microbiol. 2021;78(4):1115-1123. PubMed PMID: 33656584.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Klebsiella oxytoca and Emerging Nosocomial Infections. AU - Neog,Nakul, AU - Phukan,Upasana, AU - Puzari,Minakshi, AU - Sharma,Mohan, AU - Chetia,Pankaj, Y1 - 2021/03/03/ PY - 2020/09/19/received PY - 2021/02/10/accepted PY - 2021/3/4/pubmed PY - 2021/3/4/medline PY - 2021/3/3/entrez SP - 1115 EP - 1123 JF - Current microbiology JO - Curr Microbiol VL - 78 IS - 4 N2 - Klebsiella oxytoca is rising as a significant opportunistic pathogen causing nosocomial infections in neonates as well as adults. This pathogen's prevalence varies from 2 to 24%, but outbreaks of infections due to multidrug-resistant strains can be fatal in immunocompromised individuals with comorbidities. Klebsiella oxytoca is responsible for a wide range of ailments from colitis to infective endocarditis, other than the common urinary and respiratory tract infections. The microbe's pathogenicity has been attributed to cytotoxins' production- Tilivalline and Tilimycin, in some intestinal disorders. Klebsiella oxytoca is reported to be resistant to a wide range of antibiotics. Here, we have tried to showcase a brief overview of the emergence of Klebsiella oxytoca in healthcare facilities and the nature of resistance in this species of Klebsiella. SN - 1432-0991 UR - https://www.unboundmedicine.com/medline/citation/33656584/Klebsiella_oxytoca_and_Emerging_Nosocomial_Infections. L2 - https://dx.doi.org/10.1007/s00284-021-02402-2 DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.